Evidence map›Paper›PMID 25568082›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA.

Gaspare La Rocca, Scott H Olejniczak, Alvaro J González, Daniel Briskin, Joana A Vidigal, Lee Spraggon, Raymond G DeMatteo, Megan R Radler, Tullia Lindsten, Andrea Ventura and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. AGO2 silences mobile transposons in the nucleus of quiescent cells.Nature structural & molecular biology · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Increased Percentage of CD8Neurology(R) neuroimmunology & neuroinflammation · 2023
    Article
  20. The Multiplicity of Argonaute Complexes in Mammalian Cells.The Journal of pharmacology and experimental therapeutics · 2023
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Gaspare La RoccaCancer Biology and Genetics Program.
Scott H OlejniczakCancer Biology and Genetics Program.
Alvaro J GonzálezComputational Biology Program, and.
Daniel BriskinHoward Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY 10065.
Joana A VidigalCancer Biology and Genetics Program.
Lee SpraggonCancer Biology and Genetics Program.
Raymond G DeMatteoCancer Biology and Genetics Program.
Megan R RadlerCancer Biology and Genetics Program.
Tullia LindstenImmunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; and.
Andrea VenturaCancer Biology and Genetics Program.
Thomas TuschlHoward Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY 10065.
Christina S LeslieComputational Biology Program, and.
Craig B ThompsonCancer Biology and Genetics Program, thompsonc@mskcc.org.
Cancer Genetics (United States) · USRockefeller University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
MSKCC Center for Translational Cancer Genomic AnalysisU24CA143840 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LADANYI, MARC, SANDER, CHRIS · 2009 to 2016
$11.5M
Investigating the functions of the miR-17~92 family of oncogenic microRNA clustersR01CA149707 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VENTURA, ANDREA · 2010 to 2021
$3.8M
Cancer cell survival during factor deprivationR01CA105463 · NCI · UNIVERSITY OF PENNSYLVANIA · PI THOMPSON, CRAIG B · 2004 to 2013
$3.2M
Dissecting the role of alternative 3'UTRs in cancer with 3'-seqU01CA164190 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S, MAYR, CHRISTINE · 2012 to 2015
$2.3M
Reciprocal regulation of microRNAs and cancer-associated signaling pathwaysK99CA175189 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OLEJNICZAK, SCOTT HENRY · 2014 to 2015
$215k
Howard Hughes Medical InstituteNCI NIH HHS K99 CA175189NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA105463NCI NIH HHS R01 CA149707NCI NIH HHS U01 CA164190NCI NIH HHS U01-CA164190NCI NIH HHS U24 CA143840NCI NIH HHS U24-CA143840
6 · The paper itself

Abstract

MicroRNAs repress mRNA translation by guiding Argonaute proteins to partially complementary binding sites, primarily within the 3' untranslated region (UTR) of target mRNAs. In cell lines, Argonaute-bound microRNAs exist mainly in high molecular weight RNA-induced silencing complexes (HMW-RISC) associated with target mRNA. Here we demonstrate that most adult tissues contain reservoirs of microRNAs in low molecular weight RISC (LMW-RISC) not bound to mRNA, suggesting that these microRNAs are not actively engaged in target repression. Consistent with this observation, the majority of individual microRNAs in primary T cells were enriched in LMW-RISC. During T-cell activation, signal transduction through the phosphoinositide-3 kinase-RAC-alpha serine/threonine-protein kinase-mechanistic target of rapamycin pathway increased the assembly of microRNAs into HMW-RISC, enhanced expression of the glycine-tryptophan protein of 182 kDa, an essential component of HMW-RISC, and improved the ability of microRNAs to repress partially complementary reporters, even when expression of targeting microRNAs did not increase. Overall, data presented here demonstrate that microRNA-mediated target repression in nontransformed cells depends not only on abundance of specific microRNAs, but also on regulation of RISC assembly by intracellular signaling.

Indexed as

Argonaute ProteinsLymphocyte ActivationMicroRNAsMolecular WeightRNA, MessengerT-LymphocytesArgonaute ProteinsMicroRNAsRNA, MessengerArgonauteGW182microRNAmTORT cells

Identifiers

PMID25568082
PMCPMC4311832
OpenAlexW2054663959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.